Bioanalysis
Bioanalysis for small molecules, peptides and biologics under one method development group. LC-MS/MS and ligand-binding assays are developed, qualified and run to support PK, PD and tox studies — with sample turnaround planned around your study timeline, not ours.
OVERVIEW
Everything a sponsor evaluating an outsourced biologics CMC partner needs to know — from capacity to compliance.
Bioanalysis at ChemPartner
ChemPartner is a trusted global partner in discovery and regulated bioanalysis. We operate a premier mass spectrometry platform for small molecules, peptides, oligonucleotides, and proteins, alongside a dedicated ELISA/MSD laboratory for large molecules. Our GLP/GCLP-compliant lab is powered by Watson-LIMS, enabling end-to-end clinical sample management and data integrity.
Small Molecule & Biomarker Bioanalysis
Our team delivers high-quality qualitative and quantitative analysis of drugs, metabolites, and biomarkers across complex matrices. We routinely deploy LC-MS/MS methods to support in vitro ADME, biology, pharmacology, PK, and PK/PD studies — covering a broad range of modalities including small molecules, PROTACs, peptides, oligonucleotides, ADCs/AOCs, and PDCs.
Our instrument portfolio includes the API 7500/6500/5500, Q Exactive Orbitrap, G2-S QTOF, and over 48 MS systems in total. Annually, we develop more than 20,000 methods for discovery and biomarker support. For regulated studies, we strictly adhere to FDA, EMA, NMPA, and ICH guidelines, and provide robust toxicokinetic analysis for GLP safety assessments.
Large Molecule & Biomarker Bioanalysis
Our PK, bioanalysis, immunology, and biomarker scientists have built deep expertise across the full spectrum of large-molecule therapeutics — from conventional monoclonal, bispecific, and trispecific antibodies to complex modalities such as ADCs, PDCs, AOCs, and proTCEs. We have successfully overcome unique challenges including drug tolerance, target interference, and matrix complexity, partnering with numerous pharma and biotech companies to address demanding targets.
We offer industry-leading large-molecule PK/BA services that accelerate drug development programs through rigorous method development and validation. Designed to meet regulatory compliance (NMPA, FDA, EMA, ICH), our services ensure high-quality, reproducible data delivery from preclinical through clinical stages, advancing your candidates with confidence.
